CytoVeris
Cyto Veris Inc. is revolutionizing cancer surgery with its innovative optical-based technologies that enable surgeons to identify and remove tumor tissue more effectively during resection procedures. Their flagship product, the Tumor MAP, utilizes multispectral autofluorescence imaging and AI to provide real-time insights into tissue characteristics, enhancing surgical precision and reducing the likelihood of incomplete resections. By improving the accuracy of cancer tissue visualization, Cyto Veris aims to minimize complications and reoperations, positioning itself as a leader in the surgical oncology market. The company is focused on developing solutions that integrate seamlessly into surgical workflows, ultimately improving patient outcomes and reducing healthcare costs.
CytoVeris
Cyto Veris Inc. is revolutionizing cancer surgery with its innovative optical-based technologies that enable surgeons to identify and remove tumor tissue more effectively during resection procedures. Their flagship product, the Tumor MAP, utilizes multispectral autofluorescence imaging and AI to provide real-time insights into tissue characteristics, enhancing surgical precision and reducing the likelihood of incomplete resections. By improving the accuracy of cancer tissue visualization, Cyto Veris aims to minimize complications and reoperations, positioning itself as a leader in the surgical oncology market. The company is focused on developing solutions that integrate seamlessly into surgical workflows, ultimately improving patient outcomes and reducing healthcare costs.